UK-Based AstraZeneca Admits Covid Vaccine's Rare Blood Clot Risk In Court For First Time

AstraZeneca acknowledges in court that its Covid vaccine can cause a rare blood clotting condition, as families seek compensation in a multi-million-pound class action

Related Keywords

United Kingdom ,Cambridge ,Cambridgeshire ,British , ,Astrazeneca ,United Kingdom Based Astrazeneca ,Daily Mail ,Covid Vaccine ,Blood Clotting ,Side Effect ,Compensation ,Lass Action ,Legal Case ,Its ,Hrombosis ,Thrombocytopenia ,Mitt ,Vaccine Induced Immune Thrombotic Thrombocytopenia ,Lawsuit ,Court Admission ,Ndemnity Deal ,Vaccine Rollout ,Vaccine Damage Payment Scheme ,Vaccine Hesitancy ,Public Health ,Medical Costs ,Legal Action ,Vaccine Injury ,